Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Endothelial Dysfunction in T2DM
NCT00816218Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Mar 2003
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by UT Health San Antonio. Started Mar 2003; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00816218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816218.